Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metolachor SCHEMBL7058151 | 0.87 | MAPT (0.40) | MAPTMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| Benoxacor SCHEMBL14655536 | 0.85 | ALDH1A1 (0.36) | MAPTMEN1ALDH1A1KMT2A | |
| Metolachor SCHEMBL7059338 | 0.82 | MAPT (0.35) | MAPTMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| Metolachor SCHEMBL7062329 | 0.81 | MAPT (0.34) | MAPTMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| Metolachor SCHEMBL8145298 | 0.80 | MEN1 (0.45) | MAPTMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| Foramsulfuron SCHEMBL7055801 | 0.79 | CDK1 (0.49) | MAPTMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| Metolachor SCHEMBL7059993 | 0.73 | MEN1 (0.36) | MAPTMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| Sulfentrazone SCHEMBL7579765 | 0.72 | PPOX (0.44) | MAPTMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| Sulfentrazone SCHEMBL7576546 | 0.70 | PPOX (0.37) | MAPT | |
| Fomesafen SCHEMBL7586818 | 0.70 | MEN1 (0.36) | MAPTMEN1ALDH1A1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040242421-A1 | Herbicidal composition | SYNGENTA CROP PROTECTION, INC. | 2004-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242421-A1 | Herbicidal composition | MSRB3, MTX1, MTX2 | MAPT 4031/4885MEN1 2329/4885ALDH1A1 639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.